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Abstract
Background: Recent advances in robotic technology suggest that the utilization of the da Vinci Single-Site™
platform for cholecystectomy is safe, feasible and results in a shorter learning curve compared to conventional
single-incision laparoscopic cholecystectomy. Moreover, the robot-assisted technology has been shown to reduce
the surgeon’s stress load compared to standard single-incision laparoscopy in an experimental setup, suggesting an
important advantage of the da Vinci platform. However, the above-mentioned observations are based solely on
case series, case reports and experimental data, as high-quality clinical trials to demonstrate the benefits of the da
Vinci Single-Site™ cholecystectomy have not been performed to date.
Methods: This study addresses the question whether robot-assisted Single-Site™ cholecystectomy provides
significant benefits over single-incision laparoscopic cholecystectomy in terms of surgeon’s stress load, while
matching the standards of the conventional single-incision approach with regard to peri- and postoperative
outcomes. It is designed as a single centre, single-blinded randomized controlled trial, which compares both
surgical approaches with the primary endpoint surgeon’s physical and mental stress load at the time of surgery. In
addition, the study aims to assess secondary endpoints such as operating time, conversion rates, additional trocar
placement, intra-operative blood loss, length of hospital stay, costs of procedure, health-related quality of life,
cosmesis and complications. Patients as well as ward staff are blinded until the 1st postoperative year. Sample size
calculation based on the results of a previously published experimental setup utilizing an estimated effect size of
surgeon’s comfort of 0.8 (power of 0.8, alpha-error level of 0.05, error margin of 10–15%) resulted in a number of 30
randomized patients per arm.
Discussion: The study is the first randomized controlled trial that compares the da Vinci Single Site™ platform to
conventional laparoscopic approaches in cholecystectomy, one of the most frequently performed operations in
general surgery.
Trial registration: This trial is registered at clinicaltrials.gov (trial number: NCT02485392). Registered February 19, 2015.
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Background
Recent technological advances in both standard and ro-
botic laparoscopic technology suggest that the surgical
removal of the gallbladder can be done safely and effect-
ively using the single port technique through one small
periumbilical incision, which results in less scarring and
possibly better cosmetic and clinical outcomes for the
patient [1–6]. Despite beneficial patient-related results of
laparoscopic single port cholecystectomy compared to
the multiport laparoscopic operation, surgeons do not
feel comfortable with the single port technology [6].
Hereby, the Da Vinci Single-Site™ technology provides
several putative advantages over standard laparoscopic
single-incision approaches such as the utilization of
ergonomic, curved robot-assisted devices that preserve
triangulation within the operative field, the reassignment
of the crossing instruments to the opposite side, motion
scaling and a stable 3D view of the operating field. These
interesting features are thought to reduce eye strain, im-
prove the ergonomic outcomes for surgeons and
minimize both the mental and the physical workload as-
sociated with single-incision laparoscopy. Thus they pos-
sibly improve both surgical performance and work
satisfaction, as well as eventually impact beneficially on
patient well-being and outcome [3, 7].
Indeed, preliminary evidence from case reports and
case–control studies suggests that the utilization of the
da Vinci Single-Site™ technology for cholecystectomy is
safe, feasible and results in a shorter learning curve
compared to conventional single-incision laparoscopic
cholecystectomy [1–4]. Hereby, some of the best evi-
dence regarding robot-assisted single-site cholecystec-
tomy comes from a study by Pietrabissa [3]. They
conducted a multicenter, prospective, observational
study, which included a total of over 100 robotic proce-
dures. In this cohort, the authors reported no major in-
traoperative complications and only two of the cases
were converted to an open procedure due to inflamma-
tion. All of the participating surgeons that had previous
experience with single-incision laparoscopy cholecystec-
tomy agreed that the robotic approach is easier than the
single-incision laparoscopic technique.
Additional evidence for the benefits of the Da Vinci
platform comes from a study by Schatte and colleagues
[7]. Hereby, in a simulated experimental setup, the
computer-aided technique significantly associated with
cognitive and physical stress reduction. It has been
therefore suggested that the utilization of the da Vinci
robot system may provide several advantages to profes-
sionals who complain of fatigue and discomfort when
conducting modern surgical procedures, such as single-
incision laparoscopy. Indeed, surgeons are a group of
health care professionals who are at risk of developing
work-related musculoskeletal disorders because of many
physical and psychosocial risk factors [8, 9]. Moreover,
increases in technological complexity and equipment
that is sometimes poorly adapted to new techniques
have led surgeons to increasingly complain of fatigue
when conducting modern surgical procedures [8, 10–
13]. Importantly, it has been shown that a surgeon’s de-
gree of burnout resulting from such fatigue and discom-
fort experienced at his or her workplace is strongly
correlated with major medical errors, which in turn
carry a great risk of affecting the patient’s well being and
safety [14].
However, the described observations and putative ad-
vantages of the robotic technology are based solely on
case series, case reports and experimental data, as high-
quality clinical trials to demonstrate the benefits of the
da Vinci Single-Site™ cholecystectomy have not been per-
formed to date. The present study assesses in a random-
ized setting whether robot-assisted Single-Site™
cholecystectomy provides a significant benefit compared
with single-incision laparoscopic cholecystectomy in
terms of surgeon’s stress load as a primary endpoint.
Methods/Design
Study objectives
The study is designed as a single-blinded randomized
clinical trial with an intention to treat analysis that com-
pares Single-Site robot-assisted with single-incision lap-
aroscopic cholecystectomy. It aims to to test the
hypothesis that the robotic approach provides significant
benefits in terms of a reduced surgeon’s stress load com-
pared to the conventional single-incision approach,
while matching its standards with regard to peri- and
postoperative outcomes. The study directly compares
both surgical approaches in patients with benign gall-
bladder disease.
Endpoints and data collection
The primary endpoint of the study is the surgeon’s phys-
ical and mental stress load at the time of surgery and is
assessed by two validated visual analogue scales, specific-
ally a modified Local Experienced Discomfort (LED,
Fig. 1) and Subjective Mental Effort Questionnaire
(SMEQ, Fig. 2) [7, 15]. Secondary endpoints include
intra-operative blood loss, operating time, intra-
operative conversion rate and additional trocar place-
ment, complications, length of hospital stay, costs of
procedure, Health-Related Quality of Life (HRQoL) and
cosmesis. HRQoL and cosmesis will be assessed using
the validated Gastrointestinal Quality of Life Index
(GIQLI) and the Body Image Questionnaires (BIQ), re-
spectively [16, 17]. The exact type and time of data col-
lection is listed in detail in Table 1, the study flowchart
is depicted in Fig. 3. All data will be recorded safely
using the SecuTrial™ program. The estimated total
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For each part of the body indicated by the letters in the picture, please fill in a score as presented below
10 Extreme amount of complaints 
9
8 A lot of complaints A H
7 B I
6 Quite a lot of complaints C J
5 D K
4 Some complaints E L
3 F M
2 Hardly any complaints G N
1
0 No complaints at all
Fig. 1 Local Experienced Discomfort (LED) Questionnaire visual analogue scale
SMEQ Questionnaire
This graphic displays the amount of effort it took you to execute the procedure you have been working on. 
Please score the amount of effort by marking one of the anchors on the vertical line here below
Exceptional amount of effort
Very much effort
A lot of effort 
Fair amount of effort 
Reasonable amount of effort
Some effort
A little effort 
150
100
50
0
Fig. 2 Subjective Mental Effort Questionnaire (SMEQ) visual analogue scale
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duration of the study is 1.5 years, including the sched-
uled 1-month and 1-year postoperative follow-up visits.
At the time of writing, the study is still active and the re-
cruitment of patients has just been completed.
Inclusion criteria
Patients fulfilling the following inclusion criteria may be
enrolled in the study:
 Patient compliance and geographic proximity allow
proper preoperative check-up and postoperative
follow-up
 Written informed consent given by the patient
 Women who are not breastfeeding and are not
pregnant
 Age ≥18 years
 Symptomatic cholecystolithiasis
 Chronic cholecystitis
 Benign gallbladder polyps
Exclusion criteria
The presence of one of the following criteria will lead to
the exclusion of the subject:
 Significant systemic disease making the patient
unsuitable for abdominal surgery (ASA IV and ASA
V patients)
 Peritoneal carcinomatosis or other extensive
metastatic disease
 Mental or organic disorders which could interfere
with giving informed consent or receiving
treatments
 Contraindications to pneumoperitoneum
 Suspicion of malignant disease
 Previous extensive upper abdominal surgery (upper
gastrointestinal, hepato-pancreatico-biliary, colon,
vascular and retroperitoneal surgery via laparotomy
in the upper abdomen)
 Acute cholecystitis
 Emergency cholecystectomy
 Obesity II°-III° (BMI > 35.0 kg/m2)
All patients that have been excluded from participation
will be recorded together with the reason for the exclusion.
Randomization and blinding
Non-stratified block randomization (random block sizes
two and four) will be used to achieve balance in the
Table 1 Study outline
Schedule Enrollment Surgery Inpatient assessment 1st Outpatient follow-up 2nd Outpatient follow-upc
Assessment No. 1 2 3 4 5
Time –6 weeks to 0 0 up to 1 weekb 1mob 1 year
Informed consent x
Medical history x
In-/exclusion criteria x
Physical examination x x x (x) c
Registration x
Imaginga x
Randomization x
Questionnaire 1: LED (surgeon) x
Questionnaire :2 SMEQ (surgeon) x
Duration of surgery x
Intraoperative blood loss x
Intraoperative conversion x
Evaluation of complications x x x
Length of hospital stay x
Costs of procedure x
Questionnaire 3: HR-QoL (patient) x x x
Questionnaire 4: Cosmesis (patient) x x
Each x signifies one test, report, or procedure
aUSS and/or CT and/or MRI abdomen
bIn case of AE, inpatient assessment and/or outpatient FU-visit might exceed the given time limit; All patients will be assessed until the day of discharge and
3–4 weeks after surgery
cThe 2nd postoperative follow-up of the patient may either be done in the outpatient clinic or the assessement may be conducted by phone. In case the patient
is seen in the outpatient clinic, the insurance company of the participant will not be charged by the hospital
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allocation of participants to both treatment arms and
prevent a premature decoding of the randomization
scheme. Hereby, the patient will not be informed about
the group assignment until the last outpatient follow-up
and only after he/she has completed and returned all re-
quired questionnaires (GIQLI and BIQ).
Participating surgeons and clinic
The operation will be performed according to the group
assignment by three senior surgeons only, who have ex-
tensive experience in both robotic Single-Site and con-
ventional single-incision laparoscopy. All participating
surgeons received a one-day training in both approaches
(robotic Single Site and laparoscopic single incision
cholecystectomy). All surgeries will be performed at the
Department of Surgery at the Cantonal Hospital of Win-
terthur (Kantonsspital Winterthur) in Switzerland.
Power of the study
Sample-size calculations are based on the results of the
previously mentioned experimental setup by Schatte et
al. [7], utilizing an estimated effect size of 0.8, at a power
of 0.8 and an alpha-error level of 0.05, as well as consid-
ering a potential additional error margin of 10–15% of
the calculations (G-Power 3.1 software, Heinrich-
Heine University Duesseldorf/Germany). The sample-size
calculations resulted in a number of 30 randomized
patients per arm (60 patients in total).
Statistical analysis
For descriptive statistics, median and mean with stand-
ard deviation will be used. For inductive statistics, the
Chi-square and Fisher’s Test will be used to analyse con-
tingency tables. In normally distributed data, a paramet-
ric two-sided Student’s T-Test (unpaired) to compare the
data distributions in the two groups. In data that deviate
from normal distribution, a two-tailed Mann–Whitney
test will be applied to compare the data distributions in
the two groups. All statistical analyses will be performed
using SPSS (Version 22.0 and subsequent versions). P-
values below 0.05 will be considered significant. No in-
terim analyses are planned for the study.
Ethics
The study will be carried out in accordance with princi-
ples enunciated in the current version of the Declaration
of Helsinki, the guidelines of Good Clinical Practice
(GCP) issued by ICH, and Swiss regulatory authority’s re-
quirements. The principal investigator has completed a
GCP course (modules 1–3). The study has been approved
by the local ethics committee (Kantonale Ethikkommis-
sion Zürich, KEK-ZH-Nr. 2014–0114) and was registered
at clinicaltrials.gov (trial number: NCT02485392).
Surgical technique
The Single Site robot-assisted cholecystectomy using the
da Vinci Si platform is performed according to the
manufacturer´s instructions (Intuitive Surgical, Sunny-
vale, CA, USA). The patient is placed in supine position
under general anaesthesia, followed by surgical disinfec-
tion and sterile draping. A 2.0–2.5 cm midline intra-
umbilical incision down to the level of the fascia is cre-
ated using standard surgical technique. The fascia is in-
cised and the abdomen is entered under direct vision.
Subsequently, the fascial incision is enlarged to 2.5 cm
and a finger sweep to check for adhesions is performed.
Next, the surgeon inserts the Single-Site port using an
atraumatic clamp. The Single-Site Port has a target anat-
omy arrow indicator and five lumens: four to hold can-
nulae (one 8.5 mm da Vinci Endoscope Port, two 5 mm
Single-Site Instrument Arm Ports and one 5 mm
Accessory Port) and one lumen for the insufflation
adapter. After proper alignment of the Port, the table is
placed in reverse Trendelenburg anatomy (~10–15°)
under visual guidance (30° down endoscope) and dock-
ing is performed, whereby the patient cart approaches
the patient from the right side in a ~45° angle. In
contrast to the single incision conventional laparoscopic
approach, the robotic technique utilizes ergonomic,
curved robot-assisted laparoscopic devices that preserve
Elective cholecystectomy for
benign gall bladder disease
Inclusion/exclusion criteria
Informed consent
Randomization
Inclusion
Questionnaires
Exclusion
(recorded)
Single Site da Vinci 
Cholecystectomy
Questionnaires
Single incision laparoscopic 
Cholecystectomy
Questionnaires
Inpatient assessment Inpatient assessment
1st out patient follow up 
Questionnaires
1st out patient follow up 
Questionnaires
2nd out patient follow up 
Questionnaires
2nd out patient follow up 
Questionnaires
Fig. 3 Study flowchart
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triangulation within the operative field. The control of
the crossing instruments is independently reassigned to
the opposite side by the robotic software. The available
accessories include curved scissors, hook, clip applier,
needle driver, Cadiere grasper, Maryland retractor and
also a suction-irrigation device. In addition, a laparo-
scopic grasper is inserted through the accessory cannula,
which is utilized to retract the gallbladder fundus up and
toward the patient’s right shoulder by the first assistant
who is positioned on the left of the patient. After com-
pletion of the docking procedure, the console surgeon
first dissects the Calot’s Triangle in a standard fashion,
subsequently ligates and divides the cystic duct and ar-
tery, performs a gallbladder bed dissection and extracts
the gallbladder specimen using a 10 mm EndoPouch Re-
triever™ instrument which is inserted through the
accessory port after removal of the 5 mm assistant can-
nula. All instruments and the cannula are removed
under visual guidance, the da Vinci Si platform is
undocked and the Single Site port is removed together
with the gallbladder and the specimen bag through the
single incision. Lastly, the fascial defect is closed with 0
Vicryl and a subcuticular skin closure with 4/0 or 5/0
Monocryl is performed.
The single-incision laparoscopic cholecystectomy is
performed as previously described with slight modifica-
tions [5]. In brief, a 2.0–2.5 cm midline intra-umbilical
skin and fascia incision is performed and a SILS™ PT12
Port (Covidien Inc., Norwalk, California, USA) is intro-
duced. This port obtains four openings: one for gas in-
sufflation and three that can accommodate trocars
ranging from sizes 5 – 12 mm. A 5-mm 45° long scope
(HD EndoEye™, Olympus Europa Holding GmbH, Ham-
burg, Germany) is introduced through one of the open-
ings in the SILS™ Port. The patient is then placed in an
anti-Trendelenburg position. The fundus of the gallblad-
der is grasped and the EndoGrab™ (Virtual Ports Ltd.,
Caesarea, Israel) internally anchored retraction system is
introduced (Endograsp roticulator™, Covidien Inc., Nor-
walk, California, USA). As an alternative, the TriPort
Plus™ multitrocar port can be utilized (Olympus, Tokyo,
Japan). The dissection of the Calot’s Triangle is done
using a monopolar dissection hook. The cystic artery
and duct are first dissected and then separately clipped
with a standard 5 mm clip applicator (Covidien, Nor-
walk, California, USA). The gallbladder bed dissection is
performed and once the gallbladder is free from the ad-
jacent tissues, the 5 mm trocar is exchanged for a
10 mm trocar. An Endocatch bag (Endocatch Gold,
10 mm; Covidien Inc., Norwalk, California, USA) is
inserted and the gallbladder is extracted. The umbilical
fascia is closed using absorbable 0 Vicryl suture and a
subcuticular skin closure with 4/0 or 5/0 Monocryl is
performed.
Discussion
The study is the first randomized controlled trial that
compares the da Vinci Single Site™ platform to conven-
tional laparoscopic approaches. The putative advantages
of the robotic technique, such as a reduced surgeon’s
physical and mental stressload, could lead to a further
optimization and facilitation of laparoscopic approaches
that might ultimately result in better clinical outcomes.
In this study, the trial focuses on minimally-invasive
cholecystectomy, one of the most frequently performed
operations in general surgery. In fact, laparoscopic
cholecystectomy remains an important focus of current
surgical research efforts that aim to minimize the opera-
tive trauma and improve cosmesis without compromis-
ing safety and efficacy of this procedure. This trial
compares two modern cholecystectomy techniques,
which are likely to be adopted by the surgical commu-
nity in the future on a larger scale, in a randomized con-
trolled fashion. It utilizes a clear-cut study design with
validated techniques to assess the study endpoints and
an unbiased patient selection. The authors hope that it
will help the current and future generation of surgeons
to make an informed decision on which approach they
will adopt to treat their patients with benign gallbladder
disease.
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